A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins-Reference-Cited by-同舟云学术

A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins

Published:2017-12 Issue:6 Volume:70 Page:537-544
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Watanabe Tetsu^ORCID,Ando Kaoru,Daidoji Hyuma,Otaki Yoichiro,Sugawara Shigeo,Matsui Motoyuki,Ikeno Eiichiro,Hirono Osamu,Miyawaki Hiroshi,Yashiro Yoshinori,Nishiyama Satoshi,Arimoto Takanori,Takahashi Hiroki,Shishido Tetsuro,Miyashita Takehiko,Miyamoto Takuya,Kubota Isao

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. Effect of two intensive statin regimens on progression of coronary disease;Nicholls;N Engl J Med,2011

3. Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome

4. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial;Nissen;JAMA,2006

5. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;J Am Coll Cardiol,2014

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in risk stratification and management strategies in primary cardiovascular prevention;Atherosclerosis;2024-08

2. Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial;Med;2024-07

3. Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regression;American Journal of Preventive Cardiology;2024-06

4. Role of Lipid-Lowering and Anti-Inflammatory Therapies on Plaque Stabilization;Journal of Clinical Medicine;2024-05-25

5. Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease;Current Opinion in Cardiology;2024-03-06